Levin M, Holland P C, Nokes T J, Novelli V, Mola M, Levinsky R J, Dillon M J, Barratt T M, Marshall W C
Br Med J (Clin Res Ed). 1985 May 18;290(6480):1456-60. doi: 10.1136/bmj.290.6480.1456.
The role of platelets in the pathogenesis of vasculitis and the formation of coronary artery aneurysms was studied in 19 children with Kawasaki disease and five with polyarteritis. All patients with Kawasaki disease developed thrombocytosis in the third week of illness. The peak platelet count was significantly correlated (p less than 0.005) with the subsequent development of coronary artery aneurysms. The rise in platelet count was associated with the appearance in the circulation of a factor that induced aggregation and serotonin release in normal platelets. This factor was shown to be of high molecular weight, and its activity was lost at low pH--features suggestive of an immune complex. Immune complexes, detected by precipitation with polyethylene glycol, also appeared in the circulation as the platelet count increased. These complexes induced platelet aggregation, and there was a significant correlation (p less than 0.001) between the concentrations of IgG and IgA in the polyethylene glycol precipitated material and the platelet aggregating activity. Similar platelet aggregating activity was also detected in patients with polyarteritis but followed a different time course, persisting in the circulation for several months in association with continued disease activity. These findings imply that different mechanisms have a role in distinct phases of Kawasaki disease. The initial feverish phase (probably infective) is probably followed by an immune complex vasculitis that occurs when antibodies to the initiating agent appear in the circulation. The immune complexes aggregate platelets and induce release of serotonin. Platelet derived vasoactive mediators may increase vascular permeability and facilitate further deposition of complexes in the tissues.
对19例川崎病患儿和5例多动脉炎患儿研究了血小板在血管炎发病机制及冠状动脉瘤形成中的作用。所有川崎病患儿在病程第3周均出现血小板增多。血小板计数峰值与随后冠状动脉瘤的发生显著相关(p<0.005)。血小板计数升高与一种能诱导正常血小板聚集和5-羟色胺释放的因子在循环中出现有关。该因子显示为高分子量,其活性在低pH值时丧失,这些特征提示为免疫复合物。通过聚乙二醇沉淀检测到的免疫复合物也随着血小板计数增加而出现在循环中。这些复合物诱导血小板聚集,聚乙二醇沉淀物质中IgG和IgA的浓度与血小板聚集活性之间存在显著相关性(p<0.001)。多动脉炎患者也检测到类似的血小板聚集活性,但时间进程不同,与疾病持续活动相关,在循环中持续数月。这些发现提示不同机制在川崎病的不同阶段起作用。最初的发热期(可能为感染性)之后可能是免疫复合物性血管炎,当针对起始病原体的抗体出现在循环中时发生。免疫复合物使血小板聚集并诱导5-羟色胺释放。血小板衍生的血管活性介质可能增加血管通透性并促进复合物在组织中的进一步沉积。